"IBD" の関連情報検索結果

Merck’s IBD drug from $10.8B Prometheus deal claims its first Phase 3 win - Endpoints News



Merck’s IBD drug from $10.8B Prometheus deal claims its first Phase 3 win  Endpoints News

Scientists Uncover Cause of Inflammatory Bowel Disease Solving Decades-Old Mystery - SciTechDaily



Scientists Uncover Cause of Inflammatory Bowel Disease Solving Decades-Old Mystery  SciTechDaily

One AI Cooling Stock Is 10% Off Highs. Why IBD Says the Setup ‘Doesn’t Get Much Better’ - 24/7 Wa...



One AI Cooling Stock Is 10% Off Highs. Why IBD Says the Setup ‘Doesn’t Get Much Better’  24/7 Wall St.

Scientists Solve a 30-Year Mystery Behind Inflammatory Bowel Disease - ScienceAlert



Scientists Solve a 30-Year Mystery Behind Inflammatory Bowel Disease  ScienceAlert

Corning, IBD Stock Of The Day, Boosted By AI Data Center Play - Investor's Business Daily



Corning, IBD Stock Of The Day, Boosted By AI Data Center Play  Investor's Business Daily

Cell-type-resolved genetic variation shapes inflammatory bowel disease risk - Nature



Cell-type-resolved genetic variation shapes inflammatory bowel disease risk  Nature

Black licorice compound shows promise against inflammatory bowel disease - ScienceDaily



Black licorice compound shows promise against inflammatory bowel disease  ScienceDaily

Decades-old puzzle solved as scientists uncover cause of inflammatory bowel disease - Medical Xpress



Decades-old puzzle solved as scientists uncover cause of inflammatory bowel disease  Medical Xpress

Stocks Bounce To Close Out Wild Week; Vertiv, MaxLinear, SpaceX In Focus - Video - IBD - Investor...



Stocks Bounce To Close Out Wild Week; Vertiv, MaxLinear, SpaceX In Focus - Video - IBD  Investor's Business Daily

Merck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitis - Fierc...



Merck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitis  Fierce Biotech

NIH researchers identify regulatory cells that shield against inflammatory bowel disease - Nation...



NIH researchers identify regulatory cells that shield against inflammatory bowel disease  National Institutes of Health (.gov)

Addressing Safety Concerns with Biologic Therapies in IBD - HCPLive



Addressing Safety Concerns with Biologic Therapies in IBD  HCPLive

New biotech cAMPfield emerges with $180M to reshape IBD treatment - BioSpace



New biotech cAMPfield emerges with $180M to reshape IBD treatment  BioSpace

Merck & Co.'s tulisokibart scores pivotal TL1A victory in ulcerative colitis - FirstWord Pharma



Merck & Co.'s tulisokibart scores pivotal TL1A victory in ulcerative colitis  FirstWord Pharma

IDI Consulting Supports Crohn’s & Colitis Foundation as Silver Sponsor for Pittsburgh Take Steps ...



IDI Consulting Supports Crohn’s & Colitis Foundation as Silver Sponsor for Pittsburgh Take Steps Walk  Business Wire

Health Anxiety Mediates Self-Management in IBD - EMJ



Health Anxiety Mediates Self-Management in IBD  EMJ

Communicating About IBD Remission; Long-Term Efficacy Data on Risankizumab for CD - Gastroenterol...



Communicating About IBD Remission; Long-Term Efficacy Data on Risankizumab for CD  Gastroenterology & Endoscopy News

cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class O...



cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD  PR Newswire

Real-World Evidence in IBD: Driving Innovative Approaches to Care - AbbVie



Real-World Evidence in IBD: Driving Innovative Approaches to Care  AbbVie

Bionyra closes $165M series A to develop antibodies for inflammation - BioWorld News



Bionyra closes $165M series A to develop antibodies for inflammation  BioWorld News

cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara - Fierce Biotech



cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara  Fierce Biotech

cAMPfield raises $180M to bring PDE4 inhibition to IBD - FirstWord Pharma



cAMPfield raises $180M to bring PDE4 inhibition to IBD  FirstWord Pharma

Genetic marker may flag severe IBD earlier in some patients - Medical Xpress



Genetic marker may flag severe IBD earlier in some patients  Medical Xpress

Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm - MedCity News



Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm  MedCity News

Immune cell circuit restores barrier function in inflammatory bowel disease - Medical Xpress



Immune cell circuit restores barrier function in inflammatory bowel disease  Medical Xpress

Discovery of immune tolerance switch could yield better IBD treatments - Cornell Chronicle



Discovery of immune tolerance switch could yield better IBD treatments  Cornell Chronicle

DDW 2026: 3 Big IBD Takeaways - Docwire News



DDW 2026: 3 Big IBD Takeaways  Docwire News

Vitamin D linked to immune response to gut microbiome in inflammatory bowel disease - Mayo Clinic...



Vitamin D linked to immune response to gut microbiome in inflammatory bowel disease  Mayo Clinic News Network

New Yale Inflammatory Bowel Disease Center Responds to Growing Demand for IBD Treatment and Resea...



New Yale Inflammatory Bowel Disease Center Responds to Growing Demand for IBD Treatment and Research  Yale School of Medicine

The Bigger Cancer Risk: IBD Drugs, or IBD Itself? - Gastroenterology & Endoscopy News



The Bigger Cancer Risk: IBD Drugs, or IBD Itself?  Gastroenterology & Endoscopy News

Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn’s disease pa...



Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn’s disease pathogenesis  Nature

[Column] For Crohn’s disease and ulcerative colitis, key question is not what to avoid but what t...



[Column] For Crohn’s disease and ulcerative colitis, key question is not what to avoid but what to eat  koreabiomed.com

Advanced Merrill Lynch Interview Drill | IBD Prep Michelle Pfeiffer (fJzmAKM2CW) - Fathom Journal



Advanced Merrill Lynch Interview Drill | IBD Prep Michelle Pfeiffer (fJzmAKM2CW)  Fathom Journal

Years of experience helps launch new oral IBD treatment - UChicago Medicine



Years of experience helps launch new oral IBD treatment  UChicago Medicine

Discovery of Immune Tolerance Switch Could Yield Better IBD Treatments - WCM Newsroom



Discovery of Immune Tolerance Switch Could Yield Better IBD Treatments  WCM Newsroom

Research finds JAK inhibitors don't increase risks for patients with IBD - Mayo Clinic



Research finds JAK inhibitors don't increase risks for patients with IBD  Mayo Clinic

Treating and Managing Pediatric IBD: Care and Monitoring - Cedars-Sinai



Treating and Managing Pediatric IBD: Care and Monitoring  Cedars-Sinai

Teradyne Hits Record High, Joins 2 Best Stock Lists And Leads 17 Others To IBD 50, Big Cap 20, Mo...



Teradyne Hits Record High, Joins 2 Best Stock Lists And Leads 17 Others To IBD 50, Big Cap 20, More  Investor's Business Daily

Researchers Create Most-Complete-Yet ‘Inflammatory Bowel Disease-on-a-Chip’ - Harvard Medical School



Researchers Create Most-Complete-Yet ‘Inflammatory Bowel Disease-on-a-Chip’  Harvard Medical School

IBD Treatment: Six Things GI Doctors Wish You Knew - NYU Langone Health



IBD Treatment: Six Things GI Doctors Wish You Knew  NYU Langone Health

Vitamin D May Help Restore Immune Tolerance in Inflammatory Bowel Disease - Inside Precision Medi...



Vitamin D May Help Restore Immune Tolerance in Inflammatory Bowel Disease  Inside Precision Medicine

Diagnosis and Early Treatment in IBD - HCPLive



Diagnosis and Early Treatment in IBD  HCPLive

2.2 million-cell atlas reveals how genes drive inflammatory bowel disease risk - Medical Xpress



2.2 million-cell atlas reveals how genes drive inflammatory bowel disease risk  Medical Xpress

Study Defines Most-Precise Cancer Risk Estimates to Date for IBD Patients - NYU Langone Health



Study Defines Most-Precise Cancer Risk Estimates to Date for IBD Patients  NYU Langone Health

Decoding inflammatory bowel disease – on a chip - Wyss Institute at Harvard



Decoding inflammatory bowel disease – on a chip  Wyss Institute at Harvard

GLP-1RAs for IBD - Docwire News



GLP-1RAs for IBD  Docwire News

Wearable Technology for IBD Management: Early Insights Into Disease Activity - Gastroenterology A...



Wearable Technology for IBD Management: Early Insights Into Disease Activity  Gastroenterology Advisor

IBD Extraintestinal Manifestations After Therapy - Gastroenterology & Endoscopy News



IBD Extraintestinal Manifestations After Therapy  Gastroenterology & Endoscopy News

IBD: Vitamin D may stop immune system from attacking gut bacteria - Medical News Today



IBD: Vitamin D may stop immune system from attacking gut bacteria  Medical News Today

Precision nutrition for the prevention and management of inflammatory bowel disease - Nature



Precision nutrition for the prevention and management of inflammatory bowel disease  Nature

Johnson & Johnson advances IBD therapy, despite trial miss - statnews.com



Johnson & Johnson advances IBD therapy, despite trial miss  statnews.com

New clinic specializes in preconception, pregnancy care for patients with IBD - UChicago Medicine



New clinic specializes in preconception, pregnancy care for patients with IBD  UChicago Medicine

Improving Enrollment for Inflammatory Bowel Disease Trials Through Site Network - Docwire News



Improving Enrollment for Inflammatory Bowel Disease Trials Through Site Network  Docwire News

Engineered exosome nanovesicles for delivery of antibodies to treat inflammatory bowel disease - ...



Engineered exosome nanovesicles for delivery of antibodies to treat inflammatory bowel disease  Nature

Study Finds 1 in 3 Patients With IBD Develop Anemia - Medscape



Study Finds 1 in 3 Patients With IBD Develop Anemia  Medscape

Real world data reveal persistent gaps in long term IBD control - Drug Discovery News



Real world data reveal persistent gaps in long term IBD control  Drug Discovery News

E-News | 2026 Mountain State IBD Symposium marks another success - West Virginia University



E-News | 2026 Mountain State IBD Symposium marks another success  West Virginia University

One-Third With Inflammatory Bowel Disease Have Moderate to Severe Disability - Infectious Disease...



One-Third With Inflammatory Bowel Disease Have Moderate to Severe Disability  Infectious Disease Advisor

Redefining Treatment Expectations in IBD: From Early Control to Sustained Remission - Gastroenter...



Redefining Treatment Expectations in IBD: From Early Control to Sustained Remission  Gastroenterology Advisor

Statin Use for Primary CVD Prevention Linked to IBD Risk Reduction - Gastroenterology & Endoscopy...



Statin Use for Primary CVD Prevention Linked to IBD Risk Reduction  Gastroenterology & Endoscopy News

ACG Updates Clinical Guideline on Preventive Care in IBD - Gastroenterology & Endoscopy News



ACG Updates Clinical Guideline on Preventive Care in IBD  Gastroenterology & Endoscopy News

The Best Drug You Can't Get: How Access Barriers Shape IBD Care - Gastroenterology & Endoscopy News



The Best Drug You Can't Get: How Access Barriers Shape IBD Care  Gastroenterology & Endoscopy News

7 Tips to Help You Age Well With IBD - Everyday Health



7 Tips to Help You Age Well With IBD  Everyday Health

Exposure to per- and polyfluoroalkyl substances and inflammatory bowel disease: review and meta-a...



Exposure to per- and polyfluoroalkyl substances and inflammatory bowel disease: review and meta-analysis  Nature

GLP-1s linked to better IBD outcomes, hinting at role as ‘valuable adjunctive therapies’ - Healio



GLP-1s linked to better IBD outcomes, hinting at role as ‘valuable adjunctive therapies’  Healio

Dietary inflammatory index and objective disease activity in IBD: no association found - Nature



Dietary inflammatory index and objective disease activity in IBD: no association found  Nature

Nutrition Strategies to Induce Remission in IBD - Medscape



Nutrition Strategies to Induce Remission in IBD  Medscape

The 3 Ps of IBD today — prevention, pre-diagnosis and participation - Nature



The 3 Ps of IBD today — prevention, pre-diagnosis and participation  Nature

Evaluating the correlation between fecal and serum calprotectin in inflammatory bowel disease - N...



Evaluating the correlation between fecal and serum calprotectin in inflammatory bowel disease  Nature

Addressing Obesity in Patients With IBD: A Practical Guide - Gastroenterology & Endoscopy News



Addressing Obesity in Patients With IBD: A Practical Guide  Gastroenterology & Endoscopy News

Genetic Study Links Ancestry to IBD Severity in Hispanic Patients - Cedars-Sinai



Genetic Study Links Ancestry to IBD Severity in Hispanic Patients  Cedars-Sinai

IBD Stock Of The Day: AI Data Center, Power Grid Company Trades In Buy Zone - Investor's Business...



IBD Stock Of The Day: AI Data Center, Power Grid Company Trades In Buy Zone  Investor's Business Daily

New therapy for hard-to-treat inflammatory bowel disease shows promise - NBC News



New therapy for hard-to-treat inflammatory bowel disease shows promise  NBC News

Gut Feeling: UF Scientists Create Synthetic Mucus to Fight IBD - University of Florida



Gut Feeling: UF Scientists Create Synthetic Mucus to Fight IBD  University of Florida

New ‘IBD on a chip’ device reveals unexpected drivers of the disease - BioTechniques



New ‘IBD on a chip’ device reveals unexpected drivers of the disease  BioTechniques

The Present and Future of Monitoring Inflammatory Bowel Disease - Docwire News



The Present and Future of Monitoring Inflammatory Bowel Disease  Docwire News

Vertiv, Stock Of The Day, Offers Early Buy Point And AI-Fueled Growth - Investor's Business Daily



Vertiv, Stock Of The Day, Offers Early Buy Point And AI-Fueled Growth  Investor's Business Daily

Bionyra Pharma Launches With $165M Series A to Advance Inflammatory Disease Treatments - citybiz



Bionyra Pharma Launches With $165M Series A to Advance Inflammatory Disease Treatments  citybiz

IBD and Mental Health: 'The More We Look at This, the Crazier It Gets' - MedPage Today



IBD and Mental Health: 'The More We Look at This, the Crazier It Gets'  MedPage Today

Johnson & Johnson Advances Dual-Pathway Strategy in Refractory IBD - BioPharm International



Johnson & Johnson Advances Dual-Pathway Strategy in Refractory IBD  BioPharm International

The Rise and Reach of IBD Influencers - HealthCentral



The Rise and Reach of IBD Influencers  HealthCentral

Advanced IBD Therapies Underused, Escalation Delayed in Minority-Predominant Urban Cohort - Gastr...



Advanced IBD Therapies Underused, Escalation Delayed in Minority-Predominant Urban Cohort  Gastroenterology & Endoscopy News

Artificial intelligence in inflammatory bowel disease: bridging innovation, implementation and im...



Artificial intelligence in inflammatory bowel disease: bridging innovation, implementation and impact  Nature

Hidden Bone Health Risks for Children with IBD - Children's Hospital of Philadelphia



Hidden Bone Health Risks for Children with IBD  Children's Hospital of Philadelphia

A Practical Approach in Differentiating IBD From Other Causes of Enterocolitis - Hilmi - 2025 - J...



A Practical Approach in Differentiating IBD From Other Causes of Enterocolitis - Hilmi - 2025 - JGH Open  Wiley Online Library

Spatial Transcriptomics Guides Inflammatory Bowel Disease Research - Northwestern University



Spatial Transcriptomics Guides Inflammatory Bowel Disease Research  Northwestern University

Bacteriocin-transport–inspired oral peptide-probiotic delivery ameliorates IBD complications via ...



Bacteriocin-transport–inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis  Science | AAAS

Caffeine and IBD Risk: A Meta‐Analysis - Wu - 2026 - Journal of Gastroenterology and Hepatology -...



Caffeine and IBD Risk: A Meta‐Analysis - Wu - 2026 - Journal of Gastroenterology and Hepatology  Wiley Online Library

A Game Changer for IBD Care: The Advantages of Intestinal Ultrasound - University of Miami



A Game Changer for IBD Care: The Advantages of Intestinal Ultrasound  University of Miami

Tolerability of GLP-1 RAs in IBD - Docwire News



Tolerability of GLP-1 RAs in IBD  Docwire News

Mycophenolate Mofetil Achieves Meaningful Remission in Treatment-Resistant IBD - Docwire News



Mycophenolate Mofetil Achieves Meaningful Remission in Treatment-Resistant IBD  Docwire News

IBD Day | Miami Marlins - MLB.com



IBD Day | Miami Marlins  MLB.com

Women’s Health and IBD: Fertility, Pregnancy, Bone Health - Cedars-Sinai



Women’s Health and IBD: Fertility, Pregnancy, Bone Health  Cedars-Sinai

New Molecules Point the Way Toward Treating Crohn’s Disease - Harvard Medical School



New Molecules Point the Way Toward Treating Crohn’s Disease  Harvard Medical School

New Research Suggests Vitamin D May Help Ease IBD Symptoms - Verywell Health



New Research Suggests Vitamin D May Help Ease IBD Symptoms  Verywell Health

Decoding inflammatory bowel disease—on a chip - Medical Xpress



Decoding inflammatory bowel disease—on a chip  Medical Xpress

Hackensack University Medical Center Launches New IBD Center - Hackensack Meridian Health



Hackensack University Medical Center Launches New IBD Center  Hackensack Meridian Health

Emerging Data on Advanced Therapies for Pediatric IBD - Gastroenterology & Endoscopy News



Emerging Data on Advanced Therapies for Pediatric IBD  Gastroenterology & Endoscopy News

How a single gene shapes gut health and IBD risk - University of California, Riverside



How a single gene shapes gut health and IBD risk  University of California, Riverside

Targeting IL-23 in IBD Management - Docwire News



Targeting IL-23 in IBD Management  Docwire News